ALEXANDRIA, Va., April 7 -- United States Patent no. 12,596,126, issued on April 7, was assigned to Ute-Christiane Meier (Munich).

"Methods for the prediction, prognosis, and/or diagnosis of an inflammatory response associated with schizophrenia" was invented by Ute-Christiane Meier (Munich).

According to the abstract* released by the U.S. Patent & Trademark Office: "An in-vitro method for the prediction, prognosis and/or diagnosis of an inflammatory response associated with a condition or disease such as schizophrenia in a subject, the method comprising determining in a sample of a subject the level of 25-hydroxy vitamin D3, preferably in combination with the level of least one biomarker wherein the at least one biomarker is selected fro...